Showing results (111-120 of 131) with videos related to

Sort By:
Pageof 14
International Journal of Urology : Official Journal of the Japanese Urological Association|July 5, 2024
Survival of stage III non-seminoma testis cancer patients versus simulated controls, according to race/ethnicitySimone Morra, Cristina Cano Garcia, Mattia Luca Piccinelli, et al.
Clinical Genitourinary Cancer|May 17, 2024
Unmarried Status Effect on Stage at Presentation and Treatment Patterns in Non-Metastatic Upper Tract Urothelial Carcinoma PatientsSimone Morra, Lukas Scheipner, Andrea Baudo, et al.
BJU International|May 22, 2025
Contemporary outcomes in non-muscle-invasive bladder cancer: a large European multicentre studyMattia Longoni, Pietro Scilipoti, Mario De Angelis, et al.
European Urology Oncology|June 21, 2024
Clinical Validation of the Intermediate-risk Non-muscle-invasive Bladder Cancer Scoring System and Substratification Model Proposed by the International Bladder Cancer Group: A Multicenter Young Academic Urologists Urothelial Working Group CollaborationFrancesco Soria, Matteo Rosazza, Simone Livoti, et al.
BJU International|January 11, 2025
Gemcitabine and docetaxel for high-risk non-muscle-invasive bladder cancer: EuroGemDoce group resultsPietro Scilipoti, Mattia Longoni, Mario de Angelis, et al.
European Urology Oncology|February 20, 2026
Real-world Adherence to European Association of Urology-recommended Non-muscle-invasive Bladder Cancer Management: From Evidence-based Practice to Oncological OutcomesMattia Longoni, Pietro Scilipoti, Mario De Angelis, et al.
BJU International|March 26, 2025
The impact of histopathological evaluation at transurethral resection of bladder tumour on survival in radical cystectomy candidatesMario de Angelis, Pietro Scilipoti, Alfonso Santangelo, et al.
BJU International|February 19, 2025
Outcomes of BCG vs upfront radical cystectomy for high-risk non-muscle-invasive bladder cancerPietro Scilipoti, Mattia Longoni, Mario de Angelis, et al.
European Urology Focus|May 20, 2025
Long-term Oncological Outcomes for Patients with Non-muscle-invasive Bladder Cancer Treated with Bacillus Calmette-Guérin (BCG): A Comparative Analysis of Adequate Versus Inadequate BCG TreatmentPietro Scilipoti, Mattia Longoni, Mario de Angelis, et al.
Urologic Oncology|April 12, 2026
The impact of age in patients with non-muscle-invasive bladder cancer treated with Bacillus Calmette-GuérinPietro Scilipoti, Paolo Zaurito, Mattia Longoni, et al.
Pageof 14